1-4 of 4
Alaa A Muslimani, MD
Close
Sort by
Journal Articles

Risk Statification of Follicular Lymphomas Using Two Independent Prognostic Factors: Lymphoma Cell Size Assessment by Flow Cytometry and FDG PET Based Metabolic Activity

Mohammad Muhsin Chisti, MD, Govinda R. Brahmanday, MD, Alaa A Muslimani, MD, Siddhartha Yadav, MD, Paul Rigo, BS, Ching-yee Oliver Wong, MD, Ishmael Jaiyesimi, DO, James Huang, MD
Journal: Blood
Blood (2012) 120 (21): 5098.
https://doi.org/10.1182/blood.V120.21.5098.5098
Published: 2012
Journal Articles

Venous Thromboembolism (VTE) in Patients (pts.) with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Alaa A Muslimani, MD, Fadi Bailony, Madappa Kundranda, Timothy Spiro, Asif Chaudhry, Harris C Taylor, Ishmael Jaiyesimi, Hamed Daw
Journal: Blood
Blood (2008) 112 (11): 5340.
https://doi.org/10.1182/blood.V112.11.5340.5340
Published: 2008
Journal Articles

Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?.

Alaa A. Muslimani, MD, Timothy P. Spiro, MD, FACP, Asif A. Chaudhry, MD, Hamed A. Daw, MD
Journal: Blood
Blood (2007) 110 (11): 1878.
https://doi.org/10.1182/blood.V110.11.1878.1878
Published: 2007
Journal Articles

Successful Use of Recombinant Factor VIIa in Reversal of Life Threatening Bleeding Caused by Coagulopathy.

Alaa A. Muslimani, MD, Harneet K. Walia, MD, Manmeet S. Ahluwalia, MD, H. L. Daneschvar, MD, Hamed A. Daw, MD
Journal: Blood
Blood (2005) 106 (11): 4077.
https://doi.org/10.1182/blood.V106.11.4077.4077
Published: 2005